Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00020332 · ClinicalTrials.gov registry record · Phase 1

Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 1
Development phase
1
Study location

NCT00020332: Completed Phase 1 study of Breast Cancer, sponsored by National Cancer Institute (NCI).

NCT00020332 is a Phase 1 study of Breast Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00020332, a Phase 1 study of Breast Cancer, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 1
Development phase
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have locally advanced or metastatic breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • DRUG docetaxel
  • DRUG alvocidib

Study Locations (1)

Maryland

  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda

Trial Details

FieldValue
Start Date 2000-10
Est. Completion 2003-03
Phase Phase 1

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00020332

The ClinicalTrials.gov registry entry for NCT00020332 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which docetaxel is the first listed.

NCT00020332 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00020332 about?

NCT00020332 is a clinical study titled "Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have locally adva...

What is the current status of trial NCT00020332?

This trial is currently completed. It is a Phase 1 study. The study started on 2000-10. Estimated completion is 2003-03.

What conditions does trial NCT00020332 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00020332?

The interventions under investigation include: docetaxel (DRUG), alvocidib (DRUG).

Who is sponsoring clinical trial NCT00020332?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00020332 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.